WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Allarity Therapeutics, Inc. (NASDAQ:ALLR) between May 17, 2022 and July 19, 2024, both dates inclusive (the "Class Period"), of the important…
BALA CYNWYD, Pa., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc…
SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is conducting a thorough investigation into possible violations of securities laws by specific officers at Inari Medical, Inc. (NASDAQ:NARI), Hertz Global Holdings, Inc. …
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Iris Energy Limited (NASDAQ:IREN) between June 20, 2023 and July 11, 2024, both dates inclusive (the "Class Period"), of the important December…
VIENNA, Va., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Urgent.ly, Inc. (NASDAQ:ULY) ("Urgently"), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today announced the date for the release of its…
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities who purchased or otherwise acquired United Parcel Service, Inc. (NYSE:UPS) securities between January 30, 2024 and July 22, 2024.…
Sources: xAI is in talks with investors to raise several billion dollars in a funding round that would value it at around $40B; xAI was valued at $24B in May — New fundraising effort would substantially increase startup's valuation from…
FRANKLIN, Tenn., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced its participation in the following investor conferences:; CFO, Peter Kuipers,…
CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Bumble losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/bumble-inc?utm_campaign=mei&mktm=r&utm_source=PR&utm_medium=link&utm_campaign=bmbl&mktm=r
TransMedics Group shares fall as Q3 EPS misses estimates; revenue rises 64% but falls short of consensus. Analysts cut price targets, citing weaker transplant volumes.